Trial Profile
The effect of rheumatoid factor and anti-cyclic citrullinated peptide positivity on drug survival of abatacept in patients with rheumatoid arthritis in routine care.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 10 Feb 2016 New trial record